Agenus enrolls first patient in phase 3 colorectal cancer trial

April 1, 2026 7:30 AM

Agenus Inc. (NASDAQ: AGEN) announced the enrollment of the first patient in its global phase 3 BATTMAN trial, which will ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found